Clifford Chance

Clifford Chance advises Miura Partners on the sale of its stake in Terrats Medical

Clifford Chance has advised Miura Partners on the sale of its stake in Terrats Medical, a leading global provider of dental prosthetics, including abutments and implants to New York-based private equity firm Avista Capital Partners. As part of this transaction, Terrats Medical’ founders have reinvested in the company and will continue to lead the business. Miura will also continue to support Terrats Medical in the next phase of its growth.

Since Miura Partners's investment in 2020, Terrats Medical has implemented various initiatives to fuel growth and improve operations, including the enhancement of direct sales under the DESS® Dental Smart Solutions brand, expansion of the company’s digitization strategy, the launch of the implantology business, and the acquisitions of distributors Geryon (USA) and Humanus Dental (Sweden).

The cross-border Clifford Chance team was led by Corporate/M&A partner Guillermo Guardia, together with senior associate José María Vilaseca and associates María Viñas and Sandra Bazín. Counsel Fernando Escribano advised on tax related matters. The wider team in Spain included Senior Counsel Carme Briera (Regulatory), Counsel Begoña Barrantes (Antitrust) and Counsel Jorge Martín-Fernandez (Employment). The US team included Corporate/M&A Partner Thais García and associate Mark Sheehy. The UK team included Corporate/M&A Partner Riaz Pirmohamed and associate Thomas Cowie.